Loading...
Loading...
Investing is risky. You might not know what you'll earn, it could be hard to sell, you might own less, unexpected things can happen, and you could lose all your money.
SENTRY
Malaysia’s FIRST Healthcare & Wellness centric marketplace. Becoming a one stop solution for all healthcare needs with the largest healthcare product selection & services. We help one look after their own health effortlessly as well as take care of loved ones wherever they may reside in Malaysia.
Malaysia’s FIRST Healthcare & Wellness centric marketplace. Becoming a one stop solution for all healthcare needs with the largest healthcare product selection & services. We help one look after their own health effortlessly as well as take care of loved ones wherever they may reside in Malaysia.
MIN INVESTMENT
RM 2,100
MIN TARGET
RM 600,000
MAX TARGET
RM 2,000,000
SHARE TYPE
Ordinary Shares
SHARE PRICE
RM 210
VALUATION
RM 21,000,000
Sentry is an online store provider of medicines and healthcare products. It provides an online platform that offers prescription, over-the-counter drugs and healthcare and wellness products. It allows users to buy various healthcare products such as skincare, family care, baby care and many more. Apart from being an online store, Sentry also provide verified localized health articles from health experts and allow users to book online doctor consultation and lab tests too.
The healthcare industry has not changed much since decades ago. For years, access to quality healthcare has been a challenge for most of us and with the demands on our lives now, it is all the more important that we get comprehensive and timely healthcare from one place.
Meeting the inadequacies in the healthcare delivery system through technological interventions. The healthcare marketplace startup aims at providing a platform which would enable a consumer to gain access to healthcare services at all levels, starting from having all their clinic visits and prescriptions recorded and stored to buy medicines online and getting them delivered to their doorstep to e-consultation with doctors and scheduling diagnostic tests, thereby making it a one-stop platform for healthcare needs.
Subscription
Digital Ads
The global pharmaceuticals market was worth RM 4.08 trillion (USD $934.8 billion) in 2017, and will reach RM 5.107 trillion (USD $1.17 trillion) in 2021, growing at 5.8%. Domestically, the Malaysian pharmaceutical market is forecasted to grow from RM 10.039 billion (USD $2.3 billion) in 2015 to RM 15.714 billion (USD $3.6 billion) by 2020, representing a compound annual growth rate (CAGR) of 9.5%.
Source: The Business Research (2018), GlobalData (2016), CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia.
41.7% for research and development, 25% for marketing, 16.7% for sales, 10% for headquarter operations, 6.6% for support
Chief Executive Officer
Chief Operating Officer
Ordinary Shares
The Issuer intends to raise up to RM 2,000,000 in this fundraising exercise.
RM 600,000
RM 2,000,000
RM 210 per share
2,858 shares
9,524 shares
RM 2,100
Retail, Angel, Sophisticated, and/or Institutional Investors, subject to the applicable investment limits prescribed under the Securities Commission’s Guidelines on Recognised Markets.
14 working days after the end of the Fundraising Period.
An Investment Agreement for the subscription of the Shares (subject to review if required or necessary).
The information, calculations and remarks expressed on this term sheet or on any other part of the platform are based on information provided, disclosed and presented by the Issuer, Sentry Network Sdn Bhd to Ata Plus Sdn Bhd, either in part or in whole. Ata Plus disclaims responsibility for the accuracy, completeness and/or validity of these information, and hence will not be held liable for any inaccurate, inappropriate or incomplete information presented on this term sheet or on any other part of the platform subject to the following :
The financial information listed on the Deal page is provided by the Issuer; which includes the financial forecasts and projections, the capitalisation table, the term sheet, and management accounts.
The financial forecasts and projections have been prepared by the Issuer based on assumptions that have not been reviewed and certified by an independent certified accountant for its reasonableness.
The Issuer agrees that; all information concerning the product, business and the assets of the Issuer that have been furnished to Ata Plus Sdn Bhd for the purpose of the equity crowdfunding campaign is true, complete, and accurate in all material respects and is not misleading or deceptive whether by inclusion or omission.
Should the Investor require more information, they can do so by contacting Sentry Network Sdn Bhd directly.
(i) No shares will be alotted or issued based on this document after six months from the closing of the offer period
(ii) This issue, offer or invitation for the offering is a proposal not requiring authorisation of the Securities Commission under section 212(8) of the CMSA 2007
(iii) This document has not been reviewed by the Securities Commission Malaysia. The Securities Commission does not recommend nor assumes responsibility for any information including any statement, opinion or report disclosed in relation to this fund raising exercise and makes no representation as to its accuracy or completeness. The Securities Commission expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information disclosed.
SENTRYNETWORK_Audit_Report_Aug2020
Financial Account
Sentry Labs Busines Pitch Deck_(2) (1)
Business Plan
Sign in to access company documents and detailed information
Don't have an account? Register here
View our detailed presentation slides
RM 750,000
of RM 600,000
Min Target
RM 600,000
Max Target
RM 2,000,000
Investing in equity crowdfunding involves certain risks that include uncertainty of returns, lack of liquidity, dilution, material events and lack of control. Investments should be done as part of a diversified portfolio. ATA PLUS offers investment opportunities to investors who understands these risks in making their own investment decisions.
PLEASE READ THE FULL RISK WARNING BEFORE DECIDING TO INVEST.
This page is approved as a financial promotion by ATA PLUS Sdn. Bhd., which is authorized and regulated by the Security Commission of Malaysia. Deals that are up for investment are only offered to members of ata-plus.com on the basis of information provided by the companies concerned. ATA PLUS takes no responsibility for this information or for any recommendations or opinions made by the companies. For further information on this, please read our Term of Use.
RM 750,000
of RM 600,000
Min Target
RM 600,000
Max Target
RM 2,000,000
Min Investment
RM 2,100